Time Magazine Cover Story Examines High Prices of Prescription Drugs, Political Impact
Time magazine's cover story this week examines the high cost of prescription drugs; efforts to import cheaper, U.S.-made drugs from Canada despite the FDA's warnings about their safety and legality; and ways that the issue is "cropping up everywhere on the campaign trail." The story also examines the pharmaceutical industry's lobbying efforts and its claims that high prices are necessary for research and development costs, although "year in and year out, [the industry] ranks as the country's richest," Time reports. In addition, the story looks at state and municipal efforts to purchase prescription drugs from Canadian pharmacies and examines whether such a "roundabout way" to cut costs will provide much relief (Barlett/Steele, Time, 2/2).This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.